STAHIST AD is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Magna Pharmaceuticals, Inc.. The primary component is Chlorcyclizine Hydrochloride; Pseudoephedrine Hydrochloride.
| Product ID | 58407-625_330b36a6-17fe-47df-9fd7-d3765f27d904 |
| NDC | 58407-625 |
| Product Type | Human Otc Drug |
| Proprietary Name | STAHIST AD |
| Generic Name | Chlorcyclizine Hydrochloride And Pseudoephedrine Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-12-20 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Magna Pharmaceuticals, Inc. |
| Substance Name | CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Ingredient Strength | 25 mg/1; mg/1 |
| Pharm Classes | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2019-09-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2011-12-20 |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-12-20 |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-09-01 |
| Ingredient | Strength |
|---|---|
| CHLORCYCLIZINE HYDROCHLORIDE | 25 mg/1 |
| SPL SET ID: | ccedbc38-2479-4c35-9f86-a9f29bcfab3f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 58407-624 | Stahist AD | Chlorcyclizine Hydrochloride and Pseudoephedrine Hydrochloride |
| 58407-625 | STAHIST AD | CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE |